Skip to main content

Team Maureen

instagram

Cervical Cancer

An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses

Healthcare provider education has been associated with strong vaccine recommendation and vaccination uptake. Our objective was to create a 7-min interactive online educational tool to improve knowledge and willingness to recommend the HPV vaccine among nurses. Eighty-five percent of participants using the tool strongly agreed that the intervention improved their HPV knowledge, and 77% stated they were more likely to recommend the HPV vaccine after the intervention.

https://link.springer.com/article/10.1007/s13187-023-02352-2

HPV vaccination substantially reduces risk for invasive cervical cancer

Quadrivalent human papillomavirus (HPV) vaccination was associated with a substantial reduction in the incidence of cervical cancer in a Swedish review of more than 1 million girls and women vaccinated from 2006–2017.

With Vaccination and Screening, Cervical Cancer Could All But Disappear in North America by 2040

Cervical Cancer Mortality Rises as Women's Health Clinics Close

Cervical cancer declined dramatically in recent years in the United States, both in incidence and mortality, due to widespread availability of screening. But now researchers are reporting a trend toward more women being diagnosed with late-stage disease and significantly increased mortality.

The trend follows the closure of nearly 100 women's health clinics across the country from 2010 to 2013. This has led to an associated decrease in screening for cervical cancer and fewer women being diagnosed with early-stage disease

Fighting the Good Fight Against HPV and Cervical Cancer

An Indianapolis family advocates for HPV vaccination after losing their daughter to cervical cancer.

Wrong information creating ‘dangerous screening gap’ in cervical cancer

NHS England is warning that the misconception that lesbian, gay and bisexual (LGB) women are not at risk of cervical cancer is putting 50,000 LGB women at risk.

The ‘fake news’ has created a dangerous screening gap, as the affected women have never been for a cervical cancer screening test because they wrongly think they are not at risk.

Continue to Article

When is HPV a Problem?

There are more than 200 types of human papillomavirus, or HPV, about 40 of which can be spread sexually. The Gardasil vaccine, which is given to both men and women, protects a person from seven of the most high-risk (cancer-causing) types of HPV, as well as the two types that cause most genital warts. Most people who contract HPV will get rid of the virus on their own, but those who don’t are at risk for cancer and genital warts. This vaccine is vital in the war against HPV.

Addressing Cervical Cancer Globally Requires Scaling Up HPV Vaccination, Expanding Screening, Treatment For Women

We Have the Resources to Prevent Cervical Cancer. Do We Have the Will?
“…Although cervical cancer is the fourth most common cancer for women globally, claiming more lives than pregnancy and childbirth, we can save those lives if we can only summon the will. Health experts say that the battle against cervical cancer has two fronts. First, we need to scale up HPV vaccination to prevent cervical cancer. Second, we need to expand screening and treatment for women now in danger. These are relatively affordable, straightforward interventions that can make a big difference in a lot of lives.

Rwanda has fought to stamp out cervical cancer – they might just be the first country to do it

As Rwanda gears up for a new round of vaccinations later this year, the immunologist responsible for the vaccine that has saved so many women’s lives believes the world cannot be complacent. “You can’t be happy until everyone has been vaccinated,” Frazer says.

How Artificial Intelligence Can Detect Cervical Cancer

Researchers have developed a computer algorithm that they say can analyze digital images of a woman’s cervix and accurately identify precancerous changes that require medical attention. This artificial intelligence approach, called automated visual evaluation, has the potential to revolutionize cervical cancer screening, particularly in low-resource settings.

Women With Select Subtypes of HPV at Higher Risk for Developing High-Grade Cervical Cancer

The nested case-control Swedish study, published in Cancer, found that the presence of specific subtypes of HPV, namely HPV-16 and -18, were associated with a higher risk of developing high-grade cervical intraepithelial neoplasia (CIN) in women under the age of 30.

Hokies and Hoos take on cervical cancer treatment

Virginia Tech scientist Tim Long and University of Virginia oncologist Tim Showalter have teamed up to find a solution to alleviate stress and discomfort for women during cancer treatment.

New epigenetic cervical cancer test has 100 % detection rate

A new test for cervical cancer was found to detect all of the cancers in a randomised clinical screening trial of 15,744 women, outperforming both the current Pap smear and human papillomavirus (HPV) test at a reduced cost, according to a study led by Queen Mary University of London.

Black Women in Alabama Dying of Preventable Cancer at Alarming Rate

Black women in Alabama are dying of cervical cancer at more than twice the national average, a trend that appears to be increasing despite the disease being preventable and curable if detected early, a new Human Rights Watch report shows.

Black Women in Alabama Dying of Preventable Cancer at Alarming Rate

Cervical cancer, a disease researchers believe is on track to be eradicated within 20 years in some industrialized nations, is killing a disproportionate number of women across the American south.

Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?  

Researchers announced last month that thanks to a compulsory vaccine program, Australia is on track to eradicate cervical cancer. This is due to almost universal vaccination against human papillomavirus (HPV), a virus which isresponsible for 90 percent of cervical cancers.

Australia is about to eradicate cervical cancer, US is nowhere close. What'll it take?

WHO leads the way towards the elimination of cervical cancer

Cervical cancer is a grave threat to women’s health and lives, and globally, one woman dies of cervical cancer every two minutes. This suffering is unacceptable, particularly as cervical cancer is largely preventable.

New Clinical Trials Test Immunotherapy for Cervical Cancer

Immunotherapy has brought promising breakthroughs for several forms of cancer. Now, researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.

Patients being turned away from sexual health clinics, RCN says

New Clinical Trials Test Immunotherapy for Cervical Cancer

Immunotherapy has brought promising breakthroughs for several forms of cancer. Now, researchers are applying the knowledge they’ve gained in previous clinical trials as they look into how immunotherapy might provide additional treatment options for patients with recurrent cervical cancer.

Two Women Are Building A Pregnancy Test-Like Device To Spot Cervical Cancer

One in every 100 women in Europe will develop cervical cancer.

If diagnosed early, this can be treated. Undiagnosed, it spreads into other parts of the body - leading ultimately to death.

Yet life-saving cervical cancer screening is today at an all-time low, with many women skipping so-called ‘PAP smears’ to avoid potential discomfort at the doctors.

Could Making Cancer Screening Simpler Increase Women's Risk?

A proposal to simplify cervical cancer screening could end up missing some cancers, researchers and patient advocates say. And that could be especially true for minority women.

Sweetening connection between cancer and sugar

Scientists have found that some types of cancers have more of a sweet tooth than others.

What you should know about Cervical Cancer

Unlike many gynecologic cancers, there is a vaccination and screening test for cervical cancer, an important distinction in preventing and identifying the disease, according to Ursula Matulonis, MD, medical director of Gynecologic Oncology in Dana-Farber’s Susan F. Smith Center for Women’s Cancers, and Colleen Feltmate, MD, director of minimally invasive surgery in Gynecologic Oncology at Brigham and Women’s Hospital.

Cervical cancer is killing women at a higher rate than previously thought

Women’s risk of dying from cervical cancer may be much greater than medical professionals originally thought, according to a new study.

Wider Racial Gap Found in Cervical Cancer Deaths

The death rate from cervical cancer in the United States is considerably higher than previously estimated and the disparity in death rates between black women and white women is significantly wider, according to a study published Monday in the journal Cancer.

Nonsurgical Management of Cervical Cancer: Locally Advanced, Recurrent, and Metastatic Disease, Survivorship, and Beyond

Despite the declining incidence of cervical cancer as a result of the introduction of screening programs, globally it remains a leading cause of cancer-related death in women. Outcomes for patients who are diagnosed with anything but early-stage disease remain poor.

11 Things You Never Knew to Ask Your Gyno About Cervical Cancer

But just because this gynecologic cancer occurs less frequently doesn’t mean it’s less deadly.  In fact, cervical cancer was once the No. 1 leading cause of cancer death for women in the US. What’s worse? The disease is almost 100 percent preventable. This fact is especially chilling for Latinas, who have the highest incidence of cervical cancer and the second-highest death rate from the disease.

Half of young women unable to ‘locate vagina'

Half of young women are unable to properly label a vagina on a medical diagram, while 65 per cent have admitted they have a problem simply using the words vagina or vulva.

FDA approves Avastin to treat patients with aggressive and late-stage cervical cancer

From the link:
Avastin works by interfering with the blood vessels that fuel the development of cancerous cells. The new indication for cervical cancer is approved for use in combination with chemotherapy drugs paclitaxel and cisplatin or in combination with paclitaxel and topotecan.

Study finds genomic differences in types of cervical cancer

A new study has revealed marked differences in the genomic terrain of the two most common types of cervical cancer, suggesting that patients might benefit from therapies geared to each type’s molecular idiosyncrasies.........
.....The research was supported by grants from the American Cancer Society, the Conquer Cancer Foundation of the American Society of Clinical Oncology, the Team Maureen Cervical Cancer Fund, and the Friends of Dana-Farber Cancer Institute.

Cervical Cancer

Parental intent to initiate and complete the human papillomavirus vaccine series in the USA: a nationwide, cross-sectional survey

Human papillomavirus (HPV) vaccine uptake among US adolescents is primarily dependent on the intent of their parents. To the best of our knowledge, an analysis quantifying parental intent to initiate and complete the HPV vaccine series in the USA at both the national and state level has not been done. We aim to estimate parental intent to initiate and complete the HPV vaccine series at the national-level and state-level and to identify reasons for lack of intent to initiate and complete the vaccine series.